Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article

被引:329
|
作者
Bloch, Orin [1 ]
Han, Seunggu J. [1 ]
Cha, Soonmee [2 ]
Sun, Matthew Z. [1 ]
Aghi, Manish K. [1 ]
McDermott, Michael W. [1 ]
Berger, Mitchel S. [1 ]
Parsa, Andrew T. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
关键词
glioblastoma; survival; craniotomy; extent of resection; oncology; RECURSIVE PARTITIONING ANALYSIS; MALIGNANT GLIOMA; PROGNOSTIC-FACTORS; MULTIFORME; SURGERY; GUIDANCE; TRIAL;
D O I
10.3171/2012.9.JNS12504
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Extent of resection (EOR) has been shown to be an important prognostic factor for survival in patients undergoing initial resection of glioblastoma (GBM), but the significance of EOR at repeat craniotomy for recurrence remains unclear. In this study the authors investigate the impact of EOR at initial and repeat resection of GBM on overall survival. Methods. Medical records were reviewed for all patients undergoing craniotomy for GBM at the University of California San Francisco Medical Center from January 1, 2005, through August 15, 2009. Patients who had a second craniotomy for pathologically confirmed recurrence following radiation and chemotherapy were evaluated. Volumetric EOR was measured and classified as gross-total resection (GTR, > 95% by volume) or subtotal resection (STR, <= 95% by volume) after independent radiological review. Overall survival was compared between groups using univariate and multivariate analysis accounting for known prognostic factors, including age, eloquent location, Karnofsky Performance Status (KPS), and adjuvant therapies. Results. Multiple resections were performed in 107 patients. Fifty-two patients had initial GTR, of whom 31 (60%) had GTR at recurrence, with a median survival of 20.4 months (standard error [SE] 1.0 months), and 21(40%) had STR at recurrence, with a median survival of 18.4 months (SE 0.5 months) (difference not statistically significant). Initial STR was performed in 55 patients, of whom 26 (47%) had GTR at recurrence, with a median survival of 19.0 months (SE 1.2 months), and 29(53%) had STR, with a median survival of 15.9 months (SE 1.2 months) (p = 0.004). A Cox proportional hazards model was constructed demonstrating that age (HR 1.03, p = 0.004), KPS score at recurrence (HR 2.4, p = 0.02), and EOR at repeat resection (HR 0.62, p = 0.02) were independent predictors of survival. Extent of initial resection was not a statistically significant factor (p = 0.13) when repeat EOR was included in the model, suggesting that GTR at second craniotomy could overcome the effect of an initial STR. Conclusions. Extent of resection at recurrence is an important predictor of overall survival. If GTR is achieved at recurrence, overall survival is maximized regardless of initial EOR, suggesting that patients with initial STR may benefit from surgery with a GTR at recurrence. (http://thejns.org/doi/abs/10.3171/2012.9.JNS12504)
引用
收藏
页码:1032 / 1038
页数:7
相关论文
共 50 条
  • [1] Extent of Resection at Repeat Craniotomy for Recurrent Glioblastoma Predicts Overall Survival
    Bloch, Orin
    Han, Seunggu
    Kaur, Gurvinder
    Aghi, Manish
    McDermott, Michael
    Berger, Mitchel
    Parsa, Andrew
    [J]. JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A426 - A426
  • [2] Impact of resection on overall survival of recurrent Glioblastoma in elderly it patients
    Hager, Jasmin
    Herrmann, Eva
    Kammerer, Sarah
    Dinc, Nazife
    Won, Sae-Yeon
    Senft, Christian
    Seifert, Volker
    Marquardt, Gerhard
    Quick-Weller, Johanna
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 174 : 21 - 25
  • [3] GLIOBLASTOMA IN THE ELDERLY: THE IMPACT OF EXTENT OF RESECTION ON SURVIVAL
    Alaqeel, Ahmed
    Cadieux, Magalie
    Opoku-Darko, Michael
    Demler, Chelsea
    Kelly, John
    [J]. NEURO-ONCOLOGY, 2017, 19 : 242 - 242
  • [4] EXTENT OF REPEAT RESECTION IS PREDICTIVE OF SURVIVAL FOR RECURRENT GLIOBLASTOMA MULTIFORME
    Bloch, Orin
    Han, Seunggu J.
    Kaur, Gurvinder
    Aghi, Manish K.
    McDermott, Michael W.
    Berger, Mitchel S.
    Parsa, Andrew T.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 161 - 161
  • [5] Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging
    Coburger, Jan
    Wirtz, Christian R.
    Koenig, Ralph W.
    [J]. JOURNAL OF NEUROSURGICAL SCIENCES, 2017, 61 (03) : 233 - 244
  • [6] Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival Clinical article
    Orringer, Daniel
    Lau, Darryl
    Khatri, Sameer
    Zamora-Berridi, Grettel J.
    Zhang, Kathy
    Wu, Chris
    Chaudhary, Neeraj
    Sagher, Oren
    [J]. JOURNAL OF NEUROSURGERY, 2012, 117 (05) : 851 - 859
  • [7] Anatomical resection in glioblastoma: extent of resection and its impact on duration of survival
    Hamada, Salah M.
    Abou-Zeid, Ahmed H.
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2016, 53 (03): : 135 - 145
  • [8] Elderly patients with glioblastoma: the impact of the surgical resection extent on survival
    Vieira da Cunha, Marcelo Lemos
    Santos Esmeraldo, Augusto Cesar
    Leonardo, Augusto Wendling Henriques
    Martins dos Santos, Marcos Antonio, Jr.
    Roger Thomaz, Rotta Medeiros
    Botelho, Ricardo Vieira
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1433 - 1433
  • [9] Elderly patients with glioblastoma: the impact of surgical resection extent on survival
    Vieira da Cunha, Marcelo Lemos
    Santos Esmeraldo, Augusto Cesar
    Wendling Henriques, Leonardo Augusto
    Martins dos Santos Jr, Marcos Antonio
    Rotta Medeiros, Roger Thomaz
    Botelho, Ricardo Vieira
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (07): : 937 - 945
  • [10] Overall survival benefit from surgical resection in treatment of recurrent glioblastoma
    Mann, B. S.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (09) : 1866 - 1867